Kerstin Valinder-Strinnholm
Chairman at MOBERG PHARMA AB
Net worth: 1 M $ as of 2024-05-30
Network origin in Kerstin Valinder-Strinnholm first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
26
| Public Company | Pharmaceuticals: Major | 26 |
16
| Public Company | Biotechnology | 16 |
| Public Company | Pharmaceuticals: Major | 11 | |
| Public Company | Medical Specialties | 9 | |
Immedica Pharma AB
 Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kerstin Valinder-Strinnholm via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Lund | College/University | Masters Business Admin Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree Masters Business Admin Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal President Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Chief Executive Officer | |
| MEDIVIR AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer | |
| OREXO AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
Impilo AB
 Impilo AB Investment ManagersFinance Impilo AB (Impilo) is an independent private equity firm founded in 2016 by Sören Mellstig. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Dipylon Medical AB
 Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ECTIN RESEARCH AB | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Chairman | |
| IDOGEN AB (PUBL) | Biotechnology | Sales & Marketing Chairman Director/Board Member | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Founder Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer | |
| ONCOZENGE AB | Pharmaceuticals: Major | Chairman Sales & Marketing Director of Finance/CFO | |
| CANTARGIA AB | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| DIGNITANA AB | Medical Specialties | Director/Board Member Director/Board Member | |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Masters Business Admin | |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| VITROLIFE AB | Medical Specialties | Chief Executive Officer General Counsel | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Director of Finance/CFO Corporate Officer/Principal | |
| GHP SPECIALTY CARE AB (PUBL) | Medical/Nursing Services | Chairman Chief Executive Officer | |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
| Chalmers University of Technology | College/University | Director/Board Member Graduate Degree | |
| Medivir Personal AB | Director/Board Member Director/Board Member | ||
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Stockholm | College/University | Undergraduate Degree Masters Business Admin | |
| Centre For Advanced Medical Products | Director/Board Member Director/Board Member | ||
| ELICERA THERAPEUTICS AB | Biotechnology | Chairman Director/Board Member | |
Investor Growth Capital AB
 Investor Growth Capital AB Investment ManagersFinance Investor Growth Capital AB (IGC) is a venture capital subsidiary of Investor AB founded in 1968. The firm is headquartered Stockholm, Sweden. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| LFF Service AB | Director/Board Member Chief Executive Officer | ||
| BIOTAGE AB | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member Investor Relations Contact | |
| MEDCAP AB | Medical Specialties | Director/Board Member Director/Board Member |
Statistics
International
| Sweden | 42 |
| Denmark | 6 |
| Switzerland | 2 |
| United States | 2 |
| Netherlands | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 11 |
| Finance | 4 |
| Commercial Services | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 335 |
| Corporate Officer/Principal | 135 |
| Chairman | 94 |
| Independent Dir/Board Member | 75 |
| Chief Executive Officer | 73 |
Most connected contacts
- Stock Market
- Insiders
- Kerstin Valinder-Strinnholm
- Company connections
